FEBCX
Price
$16.85
Change
-$0.09 (-0.53%)
Updated
Jul 13 closing price
Net Assets
2.55B
RIRAX
Price
$82.58
Change
-$0.19 (-0.23%)
Updated
Jul 13 closing price
Net Assets
127.87B
Interact to see
Advertisement

FEBCX vs RIRAX

FEBCX vs RIRAX Comparison Chart in %
View a ticker or compare two or three
VS
FEBCX vs. RIRAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEBCX is a StrongBuy and RIRAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIRAX has more cash in the bank: 128B vs. FEBCX (2.55B). RIRAX pays higher dividends than FEBCX: RIRAX (2.01) vs FEBCX (1.55). FEBCX was incepted earlier than RIRAX: FEBCX (14 years) vs RIRAX (24 years). FEBCX (1.90) is less costly to investors than RIRAX (1.35). RIRAX is a more actively managed with annual turnover of: 50.00 vs. FEBCX (12.45). RIRAX has a lower initial minimum investment than FEBCX: RIRAX (250) vs FEBCX (2500). FEBCX annual gain was more profitable for investors over the last year : 15.03 vs. RIRAX (9.58). FEBCX (34.35) and RIRAX (33.27) have equivalent 5 years return.
FEBCXRIRAXFEBCX / RIRAX
Total Expense Ratio1.901.35141%
Annual Report Gross Expense Ratio1.901.35141%
Fund Existence14 years24 years-
Gain YTD6.9588.01087%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.55B128B2%
Annual Yield % from dividends1.552.0177%
Returns for 1 year15.039.58157%
Returns for 3 years37.8636.22105%
Returns for 5 years34.3533.27103%
Returns for 10 years78.5758.42135%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TRBF49.12N/A
N/A
Angel Oak Total Return ETF
SHPP33.82N/A
N/A
Pacer Industrials and Logistics ETF
SETM30.41N/A
N/A
Sprott Critical Materials ETF
BBUS135.05-1.06
-0.78%
JPMorgan BetaBuilders US Equity ETF
ROAM34.49-0.84
-2.38%
Hartford Multifactor Emerging Mkts ETF